Currently, the share price for JFL Life Sciences Ltd. is delayed. Login to view live prices.
JFL Life Sciences Ltd.
₹19.45
NSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 46.55 | +8.69% |
| Other Income | 0.52 | -68.29% |
| Total Income | 47.07 | +5.85% |
| Total Expenditure | 43.27 | +6.18% |
| EBIDT | 5.07 | -8.98% |
| Depreciation | 0.44 | +2.33% |
| Interest | 0.83 | -41.55% |
| Tax | 0.49 | -46.15% |
| Net Profit | 3.31 | +17.79% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 43.13 | +4.86% |
| Total Non-Current Assets | 13.51 | +70.37% |
| Fixed assets | 12.47 | +83.38% |
| Total assets | 56.64 | +15.45% |
| Total Current Liabilities | 19.98 | +31.27% |
| Total Non-Current Liabilities | 1.09 | -30.57% |
| Total Capital Plus Liabilities | 56.64 | +15.45% |
| Total Shareholder Funds | 35.58 | +10.26% |
| Total Debt to Equity | 0.16 | -27.27% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | 8.36 | -192.38% |
| Cash from Financing Activities | -2.31 | -128.66% |
| Cash from Investing Activities | -6.07 | -805.81% |
| Net Cash Flow | -0.03 | -76.92% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer